Risk is low in short courses

doi:10.1136/bmj.311.7002.450b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

A V HallS Tabaqchali,
S S Das,
S Tabaqchali

Senior registrar Consultant Professor of medical microbiology Department of Medical Microbiology, St Bartholomew's Hospital, London EC1A 7BE

EDITOR,--We were concerned to read Marie Doona and J Bernard Walsh's editorial on the use of chloramphenicol as topical eye medication.1 Despite the drug's widespread use, since 1966 the Committee on the Safety of Medicines has received only 11 reports of haematological reactions (all non-fatal) suspected to have been caused by ocular chloramphenicol (personal communication). In the past 10 years more than 200 million ocular topical chloramphenicol products were dispensed for community use in England alone (Department …